Top compounds associated with response to LGALS9


Feature Type Standardized
Nominal ANOVA
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA niclosamide CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.15 4e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA YM-155 CTRPv2 pan-cancer AAC -0.17 5e-05
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.22 6e-05
Download CSV